| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | B |
| 3. Samples | B |
| 4. Measurand | A |
| 5. Pre-Analytical | B |
| 6. Replicate Analysis | B |
| 7. Steady State | B |
| 8. Outlier Analysis | A |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | C |
| 12. CI | C |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | C10,11,12 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Thyroxine - free (FT4) |
| Unit | pmol / L |
| Overall Analytical Principle Method | Immunoassay; Competitive |
| Number of Subjects | 5905 |
| Number of Subjects included in BV estimation | |
| Ethinicity | Asian |
| Age Mean / Median | |
| Age Min | 0.0 |
| Age Max | 20.0 |
| Age SD | |
| Number of Males | 2598 |
| Number of Females | 3307 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 7 |
| Study Duration Units | Year |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | |
| Interval Units | Day |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 1 |
| Average Number of Samples Used for BV Estimation | |
| Average Number of Replicates | |
| Estimates of CVi | |
| Calculated Confidence Intervals of CVi | Lower: , Upper: |
| Estimates of CVg | |
| Calculated Confidence Intervals of CVg | Lower: 0.00, Upper: |
| Analytical CV | |
| Calculated Confidence Intervals of Analytical CV | Lower: , Upper: |
| Measurand Mean | |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |